Evidence map›Paper›PMID 29552652›Full record

ArticleSynthetic and systems biotechnology2017

A systems approach using OSMAC, Log P and NMR fingerprinting: An approach to novelty.

Miaomiao Liu, Tanja Grkovic, Xueting Liu, Jianying Han, Lixin Zhang, Ronald J Quinn

Abstract read
In one paragraph

Article in Synthetic and systems biotechnology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed.

  1. Review
  2. Review
  3. Actinomycin Analogs from Soil-DerivedLife (Basel, Switzerland) · 2025
    Article
  4. Article
  5. Article
  6. Potential ofMetabolites · 2024
    Review
  7. Article
  8. Article
  9. Article
  10. Advances in Microbial NMR Metabolomics.Advances in experimental medicine and biology · 2023
    Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Miaomiao LiuGriffith Institute for Drug Discovery, Griffith University, Brisbane, QLD, 4111, Australia.
Tanja GrkovicGriffith Institute for Drug Discovery, Griffith University, Brisbane, QLD, 4111, Australia.
Xueting LiuKey Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, 100101, China.
Jianying HanKey Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, 100101, China.
Lixin ZhangKey Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, 100101, China.
Ronald J QuinnGriffith Institute for Drug Discovery, Griffith University, Brisbane, QLD, 4111, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The growing number of sequenced microbial genomes has revealed a remarkably large number of secondary metabolite biosynthetic clusters for which the compounds are still unknown. The aim of the present work was to apply a strategy to detect newly induced natural products by cultivating microorganisms in different fermentation conditions. The metabolomic analysis of 4160 fractions generated from 13 actinomycetes under 32 different culture conditions was carried out by

Indexed as

MetabolitesNMR fingerprintsOSMAC

Identifiers

PMID29552652
PMCPMC5851912

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.